Published in Exp Gerontol on January 01, 1979
Maintenance of homeostasis in the aging hypothalamus: the central and peripheral roles of succinate. Front Endocrinol (Lausanne) (2015) 0.75
Hypnotic drug use among the elderly. Br Med J (Clin Res Ed) (1988) 0.75
Age-associated elevation of hypothalamic, threshold to feedback control, and its role in development, ageine, and disease. Lancet (1971) 1.37
Effect of treatment with phenformin, diphenylhydantoin or L-dopa on life span and tumour incidence in C3H/Sn mice. Gerontology (1980) 1.20
Insulin resistance, its consequences for the clinical course of the disease, and possibilities of correction in endometrial cancer. J Cancer Res Clin Oncol (2004) 1.08
Inhibition of DMBA-induced carcinogenesis by phenformin in the mammary gland of rats. Arch Geschwulstforsch (1978) 1.05
Tumor estrogen content and clinico-morphological and endocrine features of endometrial cancer. J Cancer Res Clin Oncol (2003) 0.94
Preliminary evidence on metabolic rehabilitation of cancer patients. Arch Geschwulstforsch (1988) 0.91
Hypothalmic mechanisms of ageing and of specific age pathology--I. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in the reproductive system. Exp Gerontol (1979) 0.91
Potentiation of antitumor effect of cyclophosphamide and hydrazine sulfate by treatment with the antidiabetic agent, 1-phenylethylbiguanide (phenformin). Cancer Lett (1979) 0.88
Peculiarities of hyperlipidaemia in tumour patients. Br J Cancer (1981) 0.87
Neuroendocrine-ontogenetic mechanism of aging: toward an integrated theory of aging. Int Rev Neurobiol (1986) 0.85
Ageing, metabolic immunodepression and carcinogenesis. Mech Ageing Dev (1978) 0.84
Metabolic immunodepression and metabolic immunotherapy: an attempt of improvement in immunologic response in breast cancer patients by correction of metabolic disturbances. Oncology (1982) 0.84
Mammary tumors in HER-2/NEU mice are characterized by low content of estrogen receptors-alpha and absence of progesterone receptors. Bull Exp Biol Med (2003) 0.84
Metabolic immunodepression which increases the risk of cancer. Lancet (1977) 0.83
[Inhibition of the blastomogenic effect of 7,12-dimethylbenz(a)anthracene in female rats by buformin, diphenin, a polypeptide pineal extract and L-DOPA]. Biull Eksp Biol Med (1980) 0.80
Hypothalamopituitary hyperactivity and endometrial carcinoma. Qualitative and quantitative disturbances in hormone production. Am J Obstet Gynecol (1968) 0.79
Comparative study of blood insulin levels in breast and endometrial cancer patients. Neoplasma (1997) 0.79
Hypothalamic mechanisms of ageing and of specific age pathology--V. A model for the mechanism of human specific age pathology and natural death. Exp Gerontol (1979) 0.78
[Hormonal-metabolic pattern of postmenopausal females with new onset of diabetes mellitus type 2: the role of cancer and hereditary predisposition to diabetes]. Vestn Ross Akad Med Nauk (2013) 0.78
Endocrine-metabolic criteria for distinguishing two pathogenetic types of breast cancer. Neoplasma (1977) 0.78
Expression of estrogen receptors-alpha and -beta in primary breast neoplasms and tumors exposed to neoadjuvant hormonal therapy. Bull Exp Biol Med (2004) 0.78
Resistance to inhibiting effect of dexamethasone in patients with endogenous depression. Acta Psychiatr Scand (1980) 0.78
[Characteristics of dyslipidemia in cancer patients]. Vopr Onkol (1986) 0.77
Catecholestrogens excretion in smoking and non-smoking postmenopausal women receiving estrogen replacement therapy. J Steroid Biochem Mol Biol (2000) 0.77
Increase in lifespan of rats following polypeptide pineal extract treatment. Exp Pathol (Jena) (1979) 0.76
Genotoxic factors associated with the development of receptor-negative breast cancer: potential role of the phenomenon of switching of estrogen effects. Exp Oncol (2006) 0.76
[Effect of thyroxine on the hypothalamic concentration of biogenic amines in rats of different ages]. Fiziol Zh SSSR Im I M Sechenova (1978) 0.76
[The effect of an epiphyseal extract on regulation of fat-carbohydrate metabolism]. Probl Endokrinol (Mosk) (1976) 0.76
Induction of the estrogen effect-switching phenomenon by ethanol and its correction. Neurosci Behav Physiol (2002) 0.76
[Relation of blood lipids and insulin to body fat content, body surface area and state of the subcutaneous fatty tissue in patients with breast and lung cancer]. Vopr Onkol (1985) 0.76
Hyperinsulinemia as a factor modifying sensitivity of endometrial carcinoma to hormonal influences. Eur J Gynaecol Oncol (1993) 0.76
Hypothalamic mechanisms of ageing and of specific age pathology--III. Sensitivity threshold of hypothalamo-pituitary complex to homeostatic stimuli in energy systems. Exp Gerontol (1979) 0.76
Increase with age in the hypothalamo-hypophyseal threshold to the inhibitory action of estrogens and the effect of pineal extract on this process. Bull Exp Biol Med (1974) 0.76
Hormone-metabolic status in moderately smoking breast cancer patients. Acta Oncol (1997) 0.76
Estrogen content and DNA unwinding in tumor and normal endometrial tissue of aging endometrial cancer patients. Mutat Res (1996) 0.75
[A decrease in body weight, cholesterol and blood sugar under the influence of phenformin (phenylbiguanide) in patients with cancer and atherosclerosis]. Vopr Onkol (1972) 0.75
[Correction of endocrine-metabolic disorders in oncologic patients. The effect of biguanides (phenformin and adebita), miskleron and diphenin]. Vopr Onkol (1975) 0.75
Professor Vladimir Dilman. Int J Obes Relat Metab Disord (1995) 0.75
[Search for drugs reducing the hypothalamic threshold of homeostatic control. 2-Study of Agr-310 and Agr-614 activity and that of a epiphysis extract]. Agressologie (1973) 0.75
[Neoadjuvant use of the aromatase inhibitor letrozole in uterine cancer: endocrine and clinical effects]. Vopr Onkol (2001) 0.75
Reversed action of acetylated corticotrophin: inhibition of adreno-cortical secretion. Acta Endocrinol (Copenh) (1969) 0.75
Hypothalamic mechanisms of ageing and of specific age pathology--IV. Sensitivity threshold of the hypothalamo-pituitary complex to homeostatic inhibition by thyroid. Exp Gerontol (1979) 0.75
[Induction by ethanol of 'phenomenon of switching estrogen effect' and its correction]. Ross Fiziol Zh Im I M Sechenova (2001) 0.75
[Comparison of letrozole and exemestane used in non-adjuvant therapy of endometrial carcinoma]. Vopr Onkol (2005) 0.75
[Participation of serine and histidine in formation of purine bases of nucleotides and nucleic acids in hepatoma]. Biokhimiia (1968) 0.75
Inhibition of lipolysis and potentiation of the hypoglycaemic effect of insulin by non-hypoglycaemic insulin derivatives. J Endocrinol (1971) 0.75
[The chemical composition of gonadotropins in cancer of the corpus uteri]. Vopr Onkol (1970) 0.75
Growth hormone, age and the endometrium. N Engl J Med (1970) 0.75
On the relationship between the activity of acetylation, growth of experimental tumors and efficacy of their suppression by hydrazine sulphate. Oncology (1976) 0.75
[Evaluation of ovarian status in women who received anti-tumor therapy in childhood and adolescence]. Vopr Onkol (2014) 0.75
[Comparative characteristics of hormonal status in patients with receptor-negative cancers of the breast and of the endometrium]. Vopr Onkol (2003) 0.75
Interrelation between lipidemia and somatomedin activity in cancer and age-associated pathology. Neoplasma (1982) 0.75
[The nature of hyperinsulinemia (insulin resistance) in endometrial carcinoma: of plasma levels of insulin and c-peptide]. Vopr Onkol (2000) 0.75
[Breast cancer receptor status in smoking and diabetic patients]. Vopr Onkol (2005) 0.75
[Gail's coefficient in breast cancer patients with respect to menstrual status, body mass and estrogen receptor pattern of tumor]. Vopr Onkol (2004) 0.75
[Microviscosity of erythrocyte membranes in breast cancer patients: connection with the receptor phenotype of the tumor]. Vopr Onkol (2014) 0.75
Ontogenetic model of ageing and disease formation and mechanisms of natural selection. J Theor Biol (1986) 0.75
[Genetic polymorphism of steroidogenic enzymes and steroid receptor level in tumors of the reproductive system]. Vopr Onkol (2004) 0.75
Effect of ethanol on uterotropic action of estrogens. Bull Exp Biol Med (2000) 0.75
Inhibition of lipolytic activity of human growth hormone with sheep prolactin derivative (anaprolactin). Acta Endocrinol (Copenh) (1972) 0.75
Peculiarities of hormonal regulation of adenylate cyclase and lipid composition in colonic and rectal tumors. Neoplasma (1989) 0.75
[Endocrine-genotoxic switchings as promoter of main noninfectious diseases]. Vestn Ross Akad Med Nauk (2008) 0.75
[Effect of previous diabetes therapy on tumor receptor phenotype in breast cancer: comparison of metformin and sulphonylurea derivatives]. Vopr Onkol (2010) 0.75
Dissociation of hormonal and antigenic activity of luteinizing hormone excreted in endometrial carcinoma patients (endogenous anahormones). Am J Obstet Gynecol (1973) 0.75
[Gail coefficient as a risk factor and prognosticator for the course of breast cancer: correlation with hormonal and metabolic parameters and clinical and morphologic features]. Vopr Onkol (2008) 0.75
New data on three types of anahormones (anahormones of LH, GH, ACTH, lipotropin, calcitonin and parathyroid hormone). Endocrinol Exp (1974) 0.75
[Family diabetes and its consequences in cancer patients]. Vopr Onkol (2013) 0.75
[Use of aromatase and its inhibitors in dealing with different oncological pathologies other than breast cancer]. Vopr Onkol (2007) 0.75
Anahormones of growth hormone, exophthalmic factor, melanophore-stimulating hormone, adrenocorticotropin and gonadotropin in experimental and clinical endocrinology. Int J Cancer (1966) 0.75
[Correlation of hormone-metabolic status in breast cancer and effectiveness of adjuvant hormone therapy]. Vopr Onkol (2006) 0.75
[Purine synthesis in the mouse hepatoma and liver tissue]. Vopr Onkol (1966) 0.75
Age-dependent metabolic immunodepression and cancer. IARC Sci Publ (1985) 0.75
Ageing and cancer in the light of the ontogenetic 'model of medicine'. IARC Sci Publ (1985) 0.75
[Metabolic effect of tobacco smoke and "switching" the estrogen effect: mechanism of increased genotoxicity]. Vestn Ross Akad Med Nauk (2001) 0.75
Effects of misclerone (clofibrate) on dimethylhydrazine-induced intestinal carcinogenesis in rats. Oncology (1982) 0.75
[Detection of substances lowering the hypothalamic threshold of homeostatic inhibition. III. Study of Agr 1240]. Agressologie (1977) 0.75
[Estrogen-dependence of thyroid carcinoma: testing with estradiol preparations and tamoxifen]. Vopr Onkol (2008) 0.75
[Interrelationship between response to neoadjuvant hormone therapy and hormonal-metabolic status in breast cancer patients]. Vopr Onkol (2001) 0.75
[Progenotoxic shift in mammary adipose tissue (adipogenotoxicosis): association with clinical and biological characteristics of breast cancer]. Vopr Onkol (2008) 0.75
Effect of parathyroid hormone and insulin on extracellular cyclic adenosine-3',5'-monophosphate in patients with benign and malignant breast tumors. Neoplasma (1978) 0.75
Expression of estrogen receptors-beta and aromatase activity in primary mammary gland tumors. Bull Exp Biol Med (2003) 0.75
[Switching off the estrogen effect and approaches to its correction]. Ross Fiziol Zh Im I M Sechenova (2003) 0.75
Modification of uterotropic effect of estrogens by whole-body gamma-irradiation. Bull Exp Biol Med (2001) 0.75
[Hormonal and progenotoxic properties of mammary fat in pre- and postmenopausal cancer patients]. Vopr Onkol (2006) 0.75
Modification of the uterotropic effect produced by estrogens in aging rats. Bull Exp Biol Med (2002) 0.75
[Decrease of testosterone level in blood of breast cancer patients of reproductive age after neoadjuvant chemotherapy]. Vopr Onkol (2012) 0.75
Content of 8-hydroxy-2-deoxyguanosine in steroid receptor-positive and receptor-negative breast cancer cells. Bull Exp Biol Med (2005) 0.75
[Protocol of the 500th jubilee meeting of the Society of Oncologists, devoted to the theme of "Hormone-dependent tumors -- pathogenesis and therapy," May 12, 2014]. Vopr Onkol (2014) 0.75
Study of the anti-tumor effect of polypeptide pineal extract. Oncology (1979) 0.75
[Search for drugs which decrease the hypothalamic threshold of homeostatic inhibition. I. Results of studies of the product Agr-307. (1st conclusions)]. Agressologie (1971) 0.75
Three models of medicine. (An integrated theory of aging and age-associated diseases). Med Hypotheses (1984) 0.75
[Hormonal-metabolic status of cancer patients with late-onset menopause]. Vopr Onkol (2003) 0.75